CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • REPL Dashboard
  • Financials
  • Filings
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit
  • 8-K Filing

Replimune (REPL) 8-KOther Events

Filed: 3 Jun 21, 8:03am
Free signup for more
  • Track your favorite companies
  • Receive email alerts for new filings
  • Personalized dashboard of news and more
  • Access all data and search results
Sign up for free
Search this filing
?
Pre-defined:
Table of contents
    Filing tables
    Export all tables to Excel
    Filing exhibits
    SEC
    • 8-K Current report
    • 99.1 Other Events; Financial Statements and Exhibits
    REPL similar filings
    • 9 Sep 21 Submission of Matters to a Vote of Security Holders
    • 25 Aug 21 Departure of Directors or Certain Officers
    • 6 Aug 21 Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
    • 3 Jun 21 Other Events
    • 20 May 21 Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021 Financial Results and Provides Corporate Update
    • 10 May 21 Replimune Appoints Tanya Lewis as Chief Development Operations Officer
    • 5 May 21 Other Events
    Filing view
    Share this filing

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): June 3, 2021

     

     

     

    REPLIMUNE GROUP, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware 001-38596 82-2082553
    (State or other jurisdiction
    of incorporation)
     (Commission
    File Number)
     (IRS Employer
    Identification Number)

     

    500 Unicorn Park

    Woburn, MA 01801

    (Address of principal executive offices, including Zip Code)

     

    Registrant’s telephone number, including area code: (781) 222-9600

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, par value
     $0.001 per share
     REPL The Nasdaq Stock Market LLC
     (Nasdaq Global Select Market)

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  x

     

     

     

     

     

    Item 8.01Other Events.

     

    On June 3, 2021, Replimune Group, Inc. (the “Company”) issued a news release announcing a data update from its RP1 and RP2 programs and announcing its plans to expand the development of RP2 and RP3 beyond Phase 1. A copy of the news release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein. The Company undertakes no obligation to update, supplement or amend the materials attached hereto.

     

    Item 9.01Financial Statements and Exhibits.

     

    Exhibit No. Description
       
    99.1 News Release dated June 3, 2021

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     REPLIMUNE GROUP, INC.
       
    Date: June 3, 2021By:/s/ Jean Franchi
      Jean Franchi
      Chief Financial Officer

     

     

     

    Finsight
    Resources
    • Knowledgebase
    • Log In
    • Register
    Company
    • About
    • Contact
    • Solutions
    Products
    • Deal Roadshow
    • DealVDR
    • Evercall
    • Finsight.com
    CapEdge
    • Earnings Calendar
    • Earnings Transcripts
    • EDGAR Filing Screener
    • IPO Calendar
    • Compliance
    • Privacy
    • Security
    • Terms
    AngelList LinkedIn